January 28, 2022 News by Marta Figueiredo, PhD Cortrophin Gel Now Widely Available in US for Acute Relapses ANI Pharmaceuticals has announced the full U.S. commercial availability of Cortrophin Gel (repository corticotropin injection), an injectable therapy approved for managing acute relapses in people with multiple sclerosis (MS) and other autoimmune disorders. āPatients with certain chronic autoimmune conditions often need additional treatment options,ā Mary Pao Seideman, MD,…
January 3, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Cortrophin Gel, Simvastatin, COVID-19 Treatments Cortrophin Gel Now Available in US at AllianceRx Walgreens Prime Cortrophin Gel is similar to Achtar Gel, which was, until the U.S. Food and Drug Administration’s recent re-approval of Cortrophin, the only repository corticotropin injection available in the U.S. Cortrophin Gel is a naturally produced cortisol that is expected…
December 21, 2021 News by Margarida Maia, PhD Cortrophin Gel Now Available in US at AllianceRx Walgreens Prime Cortrophin Gel (repository corticotropin injection), an injectable gel medication approved for acute flares in multiple sclerosis (MS) and other chronic autoimmune diseases, is now available through the AllianceRx Walgreens Prime specialty pharmacy to patients living in the U.S. First approved by the U.S. Food and Drug Administration (FDA)…
November 2, 2021 News by Yedida Y Bogachkov PhD FDA Approves Reintroduced Cortrophin Gel for MS Exacerbations The injectable ACTH gel medication Cortrophin Gel (repository corticotropin injection), first introduced in the U.S. in the 1950s, will now be relaunched as a treatment for acute flare-ups in multiple sclerosis (MS) and other autoimmune conditions, following its approval by the U.S. Food and Drug Administration (FDA). In…
September 2, 2021 News by Somi Igbene, PhD FDA to Review ANI’s Request for Cortrophin Gel Use The U.S. Food and Drug Administration (FDA) has agreed to review ANI Pharmaceuticalsā supplemental new drug application for the approval of Cortrophin Gel to treat people with multiple sclerosis (MS) and other chronic inflammatory conditions, including rheumatoid arthritis. Purified Cortrophin Gel (repository corticotropin injection USP) is a purified…
March 27, 2020 News by Patricia Inacio, PhD Potential Competitor to Acthar Gel Asking to Re-enter US Market ANI Pharmaceuticals is asking the U.S. Food and Drug Administration (FDA) for the right to reintroduce in the U.S. market its Cortrophin Gel (repository corticotropin injection, 80 U/ml) to treat acute exacerbations in multiple sclerosis (MS) and other diseases. Currently, the only repository corticotropin injection available in…